Lofgren's síndrome as a rare form of acute sarcoidosis
Keywords:
SARCOIDOSIS, GRANULOMATOUS DISEASE, ERYTHEMA NODOSUM, AUTOIMMUNE DISEASES.Abstract
Introduction: sarcoidosis is a granulomatous and multisystemic disease of unknown etiology defined as an inflammatory response to an environmental antigen in a genetically susceptible person. Löfgren's syndrome is a form of presentation with stereotypical clinical findings manifested as a triad of acute periarthritis, erythema nodosum and hilar adenopathy.
Case report: we report a case with the characteristic findings of this clinical form in which, after the multidisciplinary discussion of the findings found in the physical examination and complementary studies, it was decided to start treatment with glucocorticoids without performing mediastinal lymph node biopsy, an invasive and risky procedure.
Conclusions: the clinical evolution of the patient was favorable and at present he is asymptomatic, without treatment and without evidence of complications or progression towards the chronic form of the disease after three years of evolution.
Downloads
References
1. Jain R, Yadav D, Puranik N, Guleria R, Jin JO. Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments. J Clin Med[Internet]. 2020[Citado 20/05/2023]; 9(4):1081. Disponible en: https://doi.org/10.3390/jcm9041081
2. Martínez RW, Gil LG, Forteza TO, Borrajero MI. Sarcoidosis esplénica. Presentación de un caso. Breve revisión de la literatura. Revista Electrónica de Autopsia[Internet].2011[Citado 20/05/2023]; 9:1 aprox. 11p. Disponible en:https://journaldatabase.info/articles/sarcoidosis_esplenica_presentacion_un.html
3. Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med[Internet]. 2020[Citado 20/05/2023]; 201(8):e26-e51. Disponible en: https://doi.org/10.1164/rccm.202002-0251ST
4. Brown F, Modi P, Tanner LS. Lofgren Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing[Internet]; 2021[Citado 20/05/2023]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29493940
5. Polverino F, Balestro E, Spagnolo P. Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art. J Clin Med[Internet]. 2020[Citado 20/05/2023]; 9(8):2363. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32722050/
6. Fu Y, Chen Q, Yu Z, et al. Clinical application of ultrasound-guided mediastinal lymph node biopsy through cervical mediastinoscopy. Thorac Cancer[Internet]. 2021[Citado 20/05/2023];12(3):297-303. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862788/
7. Tol SJM, van der Zant FM, Knol RJJ, Wondergem M, Broos WAM. Löfgren Syndrome on 18F-FDG PET/CT: An Acute Manifestation of Sarcoidosis. Clin Nucl Med[Internet]. 2022[Citado 20/05/2023]; 47(1): 61-62. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34874349/
8. Gerke AK. Treatment of Sarcoidosis: A Multidisciplinary Approach. Front Immunol[Internet]. 2020[Citado 20/05/2023]; 11: 545413. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732561/
9. Lopez MC, Amadeu TP, Ribeiro-Alves M, et al. Defining prognosis in sarcoidosis. Medicine (Baltimore) [Internet]. 2020[Citado 20/05/2023]; 99(48): e23100. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33235069/
10. Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J[Internet]. 2021[Citado 20/05/2023]; 58(6): 2004079. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34140301/
11. Comité Nacional de Endocrinología. Consideraciones para una corticoterapia segura. Arch. Argent Pediatr[Internet]. 2018[Citado 20/05/2023]; 116(Supl3): S71-S76. Disponible en: https://www.sap.org.ar/docs/publicaciones/archivosarg/2018/v116n3a33s.pdf
12. Campbell A M, Martin J R, Erstad B L. Corticosteroid Tapering Regimens in Rheumatic Disease: A Systematic Review. J Clin Rheumatol[Internet]. 2020[Citado 20/05/2023]; 26(2): 41-47. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32073513/
13. Culver DA, Judson MA. New advances in the management of pulmonary sarcoidosis. BMJ[Internet]. 2019[Citado 20/05/2023]; 367: l5553. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31641045/j
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
